Opens in new window
July
-
22/09/2025
-
CTMUHB_314_25[Jul,IT spend, DMA and HIMSS July 2025].pdf
-
22/09/2025
-
CTMUHB_312_25[Jul,Insourcing].pdf
-
22/09/2025
-
CTMUHB_311_25[Jul,Payroll over and underpayments].pdf
-
22/09/2025
-
CTMUHB_310_25[Jul,Consultant Workforce and Programmed Activities (PAs)].pdf
-
22/09/2025
-
CTMUHB_308_25[Jul,Beds, Incidents, nurses and complaints].pdf
-
22/09/2025
-
CTMUHB_309_25[Jul,Treatment for Myelofibrosis].pdf
-
22/09/2025
-
CTMUHB_307_25[Jul,Overseas visitors].pdf
-
22/09/2025
-
CTMUHB_305_25[Jul,Endometrial cancer - SACT treatments ].pdf
-
22/09/2025
-
CTMUHB_306_25[Jul,Hip replacement].pdf
-
22/09/2025
-
CTMUHB_304_25[Jul,Myeloma].pdf
-
22/09/2025
-
CTMUHB_303_25[Jul,Medicines management software solution].pdf
-
22/09/2025
-
CTMUHB_301_25[Jul,AI systems].pdf
-
22/09/2025
-
CTMUHB_302_25[Jul,Nursing agency spend].pdf
-
22/09/2025
-
CTMUHB_300_25[Jul,Weight management policy prior to surgery].pdf
-
22/09/2025
-
CTMUHB_298_25[Jul,Formaldehyde levels ].pdf
-
22/09/2025
-
CTMUHB_297_25[Jul,Clinical incidents related to allergy].pdf
-
22/09/2025
-
CTMUHB_299_25[July,Diffuse Large B Cell Lymphoma DLBCL].pdf
-
22/09/2025
-
CTMUHB_296_25[Jul,Vascular Access Devices].pdf